Commonwealth Equity Services’s KalVista Pharmaceuticals KALV Stock Holding History

Commonwealth Equity Services’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,474	Closed	-$211K	–	4499
2026 Q1	$211K	Buy	+10,474	New	+$169K	﹤0.01%	3961

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Commonwealth Equity Services's KALV Position: Q2 2026 in Review

Commonwealth Equity Services sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 10,474 shares — an estimated $211K sold.

Commonwealth Equity Services first reported a position in KALV in Q1 2026 and held it in 1 quarter. The position peaked at $211K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Commonwealth Equity Services reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Commonwealth Equity Services sold 10,474 KalVista Pharmaceuticals shares in Q2 2026, an estimated $211K.
Commonwealth Equity Services first reported a position in KalVista Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Commonwealth Equity Services's KalVista Pharmaceuticals position peaked at $211K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.